0      0

AONN+ Annual 2021 Virtual Conference

SAT04 - Industry Sponsored Session | Cosela™: A Novel Myeloprotection Therapy Presented by G1 Therapeutics


Nov 20, 2021 10:30am ‐ Nov 20, 2021 11:30am


Description

Join G1 Therapeutics, Inc., a company focused on next-generation cancer therapies, as they review the current management of chemotherapy-induced myelosuppression (CIM). This presentation will highlight a new therapeutic approach to proactively help protect hematopoietic stem and progenitor cells in the bone marrow from chemotherapy-induced damage. Led by Tajuana Bradley, the session will outline the burden and current treatment landscape of CIM and present important information about a novel treatment. Mechanism of action, safety and efficacy data, and dosing and administration information will be discussed.

Speaker(s):

You must be logged in and own this session in order to post comments.